NYSE:GEN - Genesis Healthcare Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Genesis Healthcare Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $1.66 0.00 (0.00 %) (As of 02/20/2020 09:34 AM ET) Add Compare Today's Range$1.66Now: $1.66▼$1.6650-Day Range$1.50MA: $1.58▼$1.6652-Week Range$0.92Now: $1.66▼$1.79VolumeN/AAverage Volume120,752 shsMarket Capitalization$273.57 millionP/E RatioN/ADividend YieldN/ABeta1.1 ProfileAnalyst RatingsAdvanced ChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Genesis Healthcare, Inc, together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services, Rehabilitation Therapy Services, and All Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy. Read More… Industry, Sector and Symbol Stock Exchange NYSE Industry Skilled nursing care facilities Sub-IndustryN/A SectorMedical Current SymbolNYSE:GEN Previous SymbolNYSE:SKH CUSIPN/A CIK1351051 Webhttp://www.genesishcc.com/ Phone610-444-6350Debt Debt-to-Equity RatioN/A Current Ratio0.76 Quick Ratio0.76Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$4.98 billion Price / Sales0.05 Cash Flow$0.43 per share Price / Cash Flow3.84 Book Value($12.65) per share Price / Book-0.13Profitability EPS (Most Recent Fiscal Year)($1.55) Net Income$-235,230,000.00 Net Margins-0.93% Return on EquityN/A Return on Assets-0.94%Miscellaneous Employees61,300 Outstanding Shares164,800,000Market Cap$273.57 million Next Earnings Date3/16/2020 (Estimated) OptionableOptionable Receive GEN News and Ratings via Email Sign-up to receive the latest news and ratings for GEN and its competitors with MarketBeat's FREE daily newsletter. GEN Rates by TradingView Genesis Healthcare (NYSE:GEN) Frequently Asked Questions What is Genesis Healthcare's stock symbol? Genesis Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "GEN." How were Genesis Healthcare's earnings last quarter? Genesis Healthcare Inc (NYSE:GEN) issued its earnings results on Thursday, November, 7th. The company reported $0.40 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.09) by $0.49. The firm had revenue of $1.12 billion for the quarter, compared to analysts' expectations of $1.13 billion. View Genesis Healthcare's Earnings History. When is Genesis Healthcare's next earnings date? Genesis Healthcare is scheduled to release their next quarterly earnings announcement on Monday, March 16th 2020. View Earnings Estimates for Genesis Healthcare. Has Genesis Healthcare been receiving favorable news coverage? Media stories about GEN stock have trended negative this week, according to InfoTrie Sentiment. InfoTrie identifies positive and negative media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Genesis Healthcare earned a daily sentiment score of -2.1 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for Genesis Healthcare. Who are some of Genesis Healthcare's key competitors? Some companies that are related to Genesis Healthcare include Akebia Therapeutics (AKBA), Phibro Animal Health (PAHC), Twist Bioscience (TWST), Krystal Biotech (KRYS), Luminex (LMNX), Enanta Pharmaceuticals (ENTA), Portola Pharmaceuticals (PTLA), Natus Medical (NTUS), Opko Health (OPK), Adverum Biotechnologies (ADVM), Myovant Sciences (MYOV), Knight Therapeutics (GUD), Karyopharm Therapeutics (KPTI), Dermira (DERM) and Cryolife (CRY). What other stocks do shareholders of Genesis Healthcare own? Based on aggregate information from My MarketBeat watchlists, some companies that other Genesis Healthcare investors own include Flaherty&Crumrine Prfrd Scts Incm Fd (FFC), Vaxart (VXRT), Advanced Micro Devices (AMD), Amarin (AMRN), Anavex Life Sciences (AVXL), Aduro BioTech (ADRO), Agile Therapeutics (AGRX), Government Properties Income Trust (GOV), Inovio Pharmaceuticals (INO) and Nabriva Therapeutics (NBRV). Who are Genesis Healthcare's key executives? Genesis Healthcare's management team includes the folowing people: Mr. George V. Hager Jr., CEO & Director (Age 63)Mr. Thomas DiVittorio, CFO, Exec. VP, Treasurer & Assistant Sec. (Age 51)Mr. Paul David Bach, COO & Exec. VP (Age 60)Dr. JoAnne Susan Reifsnyder Ph.D., MSN, MBA, FAAN, Exec. VP of Clinical Operations & Chief Nursing Officer (Age 60)Mr. Richard L. Castor, Chief Information Officer & Sr. VP (Age 64) Who are Genesis Healthcare's major shareholders? Genesis Healthcare's stock is owned by a number of of institutional and retail investors. Top institutional investors include First Washington CORP (2.54%), Renaissance Technologies LLC (2.53%), Chevy Chase Trust Holdings Inc. (1.59%), Acadian Asset Management LLC (0.98%), State Street Corp (0.73%) and Panagora Asset Management Inc. (0.59%). Company insiders that own Genesis Healthcare stock include David A Reis, Joanne Susan Reifsnyder, Michael Scott Sherman, Paul David Bach, Stephen Scott Young and Thomas Divittorio. View Institutional Ownership Trends for Genesis Healthcare. Which institutional investors are selling Genesis Healthcare stock? GEN stock was sold by a variety of institutional investors in the last quarter, including BSW Wealth Partners, Goldman Sachs Group Inc., Virtu Financial LLC, California Public Employees Retirement System and Principal Financial Group Inc.. Company insiders that have sold Genesis Healthcare company stock in the last year include Joanne Susan Reifsnyder, Michael Scott Sherman, Paul David Bach and Thomas Divittorio. View Insider Buying and Selling for Genesis Healthcare. Which institutional investors are buying Genesis Healthcare stock? GEN stock was purchased by a variety of institutional investors in the last quarter, including First Washington CORP, Renaissance Technologies LLC, Chevy Chase Trust Holdings Inc., Panagora Asset Management Inc., State Street Corp, Acadian Asset Management LLC, Barclays PLC and UBS Group AG. View Insider Buying and Selling for Genesis Healthcare. How do I buy shares of Genesis Healthcare? Shares of GEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is Genesis Healthcare's stock price today? One share of GEN stock can currently be purchased for approximately $1.66. How big of a company is Genesis Healthcare? Genesis Healthcare has a market capitalization of $273.57 million and generates $4.98 billion in revenue each year. The company earns $-235,230,000.00 in net income (profit) each year or ($1.55) on an earnings per share basis. Genesis Healthcare employs 61,300 workers across the globe.View Additional Information About Genesis Healthcare. What is Genesis Healthcare's official website? The official website for Genesis Healthcare is http://www.genesishcc.com/. How can I contact Genesis Healthcare? Genesis Healthcare's mailing address is 101 EAST STATE STREET, KENNETT SQUARE PA, 19348. The company can be reached via phone at 610-444-6350 or via email at [email protected] MarketBeat Community Rating for Genesis Healthcare (NYSE GEN)Community Ranking: 2.7 out of 5 ( )Outperform Votes: 425 (Vote Outperform)Underperform Votes: 376 (Vote Underperform)Total Votes: 801MarketBeat's community ratings are surveys of what our community members think about Genesis Healthcare and other stocks. Vote "Outperform" if you believe GEN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GEN will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/20/2020 by MarketBeat.com StaffFeatured Article: What is a stock split?
